Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

News & Analysis

China biotech company and industry news and analysis...

Week in Review: Shanghai's Zenas Acquires CD19 Antibody from Xenco in $480 Million Deal

3D Medicines Approved to Launch Anti-PD-L1 in China

Tongshu Biotechnology Raises $78 Million for Early Cancer Screening Tests

WuXi AppTech Co-Founders Make $20 Million Gift for Cancer Research

Neurophth Closes $60 Million C Round for Ophthalmic Gene Therapies

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China